NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric

A rubric for evaluating the FAIRness of NIH-CFDE Resources

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (626384)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license NIH program name is available for querying NIH project name is available for querying The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible
MEMA HMEC122L Staining Set 4 LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
JNK-IN-8 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
iMN (Exp 2) - ALS, SMA and Control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol - Proteomics LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AZ-628 KiNativ -- dose response experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA HMEC122L Staining Set C LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Transcriptomics dataset (August 2015) LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Sorafenib KiNativ -- dose response experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Tyrosine Kinase Inhibitor-induced cardiotoxicity in hiPSC derived cardiomyocytes - pilot dataset LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
PLSR model loadings (pMEK and pERK included) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA HMEC240L Staining Set 1 LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
QL-X-138 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
PCI-32765 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BMS345541 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Buparlisib KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
A770041 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AMG-706 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BMS-345541 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yesbut (0.72)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CGP082996 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CH5424802 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yesbut (0.76)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Basal profile of receptor tyrosine kinase signaling network measured by ELISA LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.84)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics. LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AT-7519 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019